Target & Activity
| Target | Activity | Value |
|---|---|---|
| TLR9 | ||
| Autophagy |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| Vero C1008 | CC50 | > 40 μM | Cytotoxicity (CC50) determination in Vero E6 cells measured by fluorescence (OD590nm) | 10.1101/2020.04.03.023846 |
| Vero C1008 | CC50 | >> 50 μM | CC50 determination at MOI 0.004 using CellTiter- Glo (CTG) assay, performed 3 days post-infection in Vero E6 cells | 10.1101/2020.03.25.008482 |
| Vero C1008 | CC50 | >> 50 μM | CC50 determination at MOI 0.01 using CellTiter- Glo (CTG) assay, performed 3 days post-infection in Vero E6 cells | 10.1101/2020.03.25.008482 |
| Vero C1008 | IC50 | 11.17 μM | IC50 determination at MOI 0.01 using CellTiter- Glo (CTG) assay, performed 3 days post-infection in SARS-CoV-2 infected Vero E6 cells | 10.1101/2020.03.25.008482 |
| Vero C1008 | EC50 | 4.17 μM | Antiviral efficacy against SARS-CoV-2 (strain BavPat1) in Vero E6 cells assessed by inhibition of viral RNA replication measured by RT-PCR after 2 days | 10.1101/2020.04.03.023846 |
| Vero C1008 | IC50 | 9.21 μM | IC50 determination at MOI 0.004 using CellTiter- Glo (CTG) assay, performed 3 days post-infection in SARS-CoV-2 infected Vero E6 cells | 10.1101/2020.03.25.008482 |